nitrofurantoin has been researched along with Disease Models, Animal in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (84.62) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (15.38) | 2.80 |
Authors | Studies |
---|---|
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
Alsaid, O; Barakat, A; Elawady, M; Elkholy, A; Kishik, S; Soror, A; Wassef, R | 1 |
Galimberti, E; Gomarasca, P; Sperandeo, F | 1 |
Hatala, M; Konícková, L; Prát, V; Ritzerfeld, W | 1 |
Burrous, SE; Eudy, WW; Siedler, AJ | 1 |
Maronpot, RR | 1 |
Hatala, M; Konicková, L; Prát, V | 2 |
Barros, M; da Silva Teles, E; Rocha, H | 1 |
Burrous, SE; Cawein, JB | 1 |
English, AR | 1 |
Lisitsa, LI; Rudzit, EA | 1 |
Konícková, L; Prát, V | 1 |
1 review(s) available for nitrofurantoin and Disease Models, Animal
Article | Year |
---|---|
[Experimental pyelonephritis, chemotherapeutic studies (review of the literature)].
Topics: Acute Disease; Ampicillin; Animals; Anti-Bacterial Agents; Chloramphenicol; Chronic Disease; Corynebacterium; Disease Models, Animal; Dogs; Escherichia coli Infections; Gentamicins; Haplorhini; Kidney; Ligation; Mice; Nalidixic Acid; Nitrofurantoin; Penicillin G; Proteus Infections; Pseudomonas Infections; Pyelonephritis; Rabbits; Rats; Staphylococcal Infections; Streptococcal Infections; Streptomycin; Sulfonamides; Tetracycline; Ureter | 1971 |
12 other study(ies) available for nitrofurantoin and Disease Models, Animal
Article | Year |
---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Evaluation of mono and combined nitrofurantoin therapy for toxoplasmosis
Topics: Animals; Disease Models, Animal; Female; Humans; Mice; Nitrofurantoin; Persistent Infection; Spiramycin; Toxoplasma; Toxoplasmosis | 2023 |
[Prevention of experimental neuritis induced by nitrofurantoin and triorthocresylphosphate].
Topics: Adrenal Cortex; Animals; Cresols; Disease Models, Animal; Male; Nitrofurantoin; Organophosphorus Compounds; Polyneuropathies; Rats; Tissue Extracts | 1977 |
[Models of urinary infection].
Topics: Animals; Bacterial Infections; Bacteriuria; Carbenicillin; Disease Models, Animal; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Gentamicins; Kanamycin; Kidney; Mice; Nitrofurantoin; Pseudomonas; Pseudomonas Infections; Pyelonephritis; Rabbits; Rats; Sulfadiazine; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections | 1974 |
Enhancement of ampicillin efficacy by peroral levodopa in rat pyelonephritis.
Topics: Administration, Oral; Ampicillin; Animals; Catechols; Cephalothin; Dihydroxyphenylalanine; Disease Models, Animal; Drug Synergism; Edetic Acid; Escherichia coli Infections; Nitrofurantoin; Phenylacetates; Pyelonephritis; Rats; Time Factors | 1972 |
Erythrocyte glucose-6-phosphate dehydrogenase and glutathione deficiency in sheep.
Topics: Age Factors; Animals; Chromium Isotopes; Disease Models, Animal; Erythrocytes; Female; Glucosephosphate Dehydrogenase; Glucosephosphate Dehydrogenase Deficiency; Glutathione; Hemolysis; Male; Methylene Blue; Nitrofurantoin; Primaquine; Pyrimethamine; Sex Factors; Sheep | 1972 |
[Effect of the combination of nitrofurantoin and sulfadiazine in experimental E. coli cystitis].
Topics: Animals; Bacteriuria; Cystitis; Disease Models, Animal; Escherichia coli Infections; Female; Nitrofurantoin; Rats; Sulfadiazine; Urine | 1972 |
Site of action of nitrofurantoin in experimental urinary tract infection.
Topics: Animals; Bacteriuria; Disease Models, Animal; Escherichia coli Infections; Kidney; Nitrofurantoin; Proteus Infections; Pyelonephritis; Rats; Urinary Tract Infections | 1969 |
Rat pyelonephritis model suitable for primary or secondary screening.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Disease Models, Animal; Escherichia coli Infections; Female; Gentamicins; Male; Nalidixic Acid; Nitrofurantoin; Proteus Infections; Pyelonephritis; Rats; Sulfamethoxazole; Sulfisoxazole | 1969 |
Activity of tetracyclines, nalidixic acids, and nitrofurantoin in two experimental models of Escherichia coli urinary tract disease in rats.
Topics: Animals; Cell Count; Disease Models, Animal; Escherichia coli Infections; Female; Kidney; Nalidixic Acid; Nitrofurantoin; Oxytetracycline; Pyelonephritis; Rats; Tetracycline; Urinary Tract Infections | 1971 |
[Long-term therapy of experimental E. coli cystitis with combination of sulfadiazine and nitrofurantoin].
Topics: Animals; Cystitis; Disease Models, Animal; Drug Synergism; Escherichia coli Infections; Female; Nitrofurantoin; Rats; Sulfadiazine; Time Factors | 1971 |
[Importance of animal experiments for antibcterial therapy of infection of the urinary tract in man].
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Nalidixic Acid; Nitrofurantoin; Rats; Sulfamethazine; Urinary Tract Infections | 1971 |